These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 6096979

  • 1. [Dynamics of beta-lipotropin and beta-endorphin levels in Itsenko-Cushing disease patients being treated with the antiserotonin preparation cyproheptadine (peritol) and chloditan].
    Slavnov VN, Valueva GV, Luchitskiĭ EV.
    Ter Arkh; 1984; 56(9):119-22. PubMed ID: 6096979
    [Abstract] [Full Text] [Related]

  • 2. Effect of the antiserotonin drug, cyproheptadine, on plasma beta-endorphin and beta-lipotropin in patients with Itsenko-Cushing's disease.
    Slavnov VN, Valueva GV, Luchitsky EV.
    Exp Clin Endocrinol; 1985 Jun; 85(3):341-50. PubMed ID: 2995088
    [Abstract] [Full Text] [Related]

  • 3. [Dynamics of secretion of hypothalamo-hypophyseal system hormones in Itsenko-Cushing disease as affected by combination therapy].
    Slavnov VN, Valueva GV, Luchitskiĭ EV, Komissarenko IV, Cheban AK.
    Probl Endokrinol (Mosk); 1983 Jun; 29(6):28-32. PubMed ID: 6140677
    [Abstract] [Full Text] [Related]

  • 4. [Potential use of the antiserotonin preparation cyproheptadine (peritol) in Itsenko-Cushing disease].
    Valueva GV, Luchitskiĭ EV, Iakovlev AA.
    Farmakol Toksikol; 1983 Jun; 46(2):50-3. PubMed ID: 6852218
    [Abstract] [Full Text] [Related]

  • 5. [Neurotensin in Itsenko-Cushing disease].
    Slavnov VN, Luchitskiĭ EV, Iakovlev AA, Komissarenko IV, Valueva GV.
    Probl Endokrinol (Mosk); 1984 Jun; 30(4):35-40. PubMed ID: 6382246
    [Abstract] [Full Text] [Related]

  • 6. [Blood levels of beta-endorphin and beta-lipotropin in patients with Cushing's syndrome].
    Slavnov VN, Valueva GV, Luchitskiĭ EV, Iakovlev AA.
    Ter Arkh; 1981 Jun; 53(12):107-10. PubMed ID: 6278666
    [No Abstract] [Full Text] [Related]

  • 7. [Function of the hypophysis in patients with Itsenko-Cushing disease treated with peritol and chloditan].
    Slavnov VN, Valueva GV, Luchitskiĭ EV.
    Klin Med (Mosk); 1983 Oct; 61(10):27-31. PubMed ID: 6417399
    [No Abstract] [Full Text] [Related]

  • 8. [Prolactin secretion in Itsenko-Cushing disease patients treated with chloditan and peritol].
    Slavnov VN, Luchitskiĭ EV, Komissarenko IV, Cheban AK.
    Probl Endokrinol (Mosk); 1982 Oct; 28(4):39-44. PubMed ID: 7122445
    [Abstract] [Full Text] [Related]

  • 9. The use of cyproheptadine (peritol) as a drug blocking corticotropin secretion in the treatment of Itsenko-Cushing's disease.
    Komissarenko IV, Cheban AK, Rybakov SI, Pomerantsev YuV, Slavnov VI, Luchitskii EV.
    Neurosci Behav Physiol; 1982 Oct; 12(6):494-6. PubMed ID: 6314174
    [No Abstract] [Full Text] [Related]

  • 10. [Changes in the secretion of the hormones of the hypothalamo-hypophyseo-adrenal system in Itsenko-Cushing disease under the influence of insulin-induced hypoglycemia and thyroliberin].
    Slavnov VN, Luchitskiĭ EV.
    Vrach Delo; 1990 Mar; (3):72-5. PubMed ID: 2164280
    [Abstract] [Full Text] [Related]

  • 11. [ACTH, beta-endorphin and lipotropins: physiopathological studies in man (author's transl)].
    Kuhn JM, Luton JP, Bricaire H.
    Ann Med Interne (Paris); 1982 Mar; 133(3):148-51. PubMed ID: 6285791
    [Abstract] [Full Text] [Related]

  • 12. Human plasma ACTH, lipotropin, and endorphin.
    Krieger DT, Yamaguchi H, Liotta AS.
    Adv Biochem Psychopharmacol; 1981 Mar; 28():541-56. PubMed ID: 6259909
    [No Abstract] [Full Text] [Related]

  • 13. [Use of cyproheptadine in the treatment of Cushing's disease].
    Jannì A, Carmina E, Lanzara P, Lo Coco R, Longo RA.
    Clin Ter; 1979 Feb 28; 88(4):345-54. PubMed ID: 222530
    [No Abstract] [Full Text] [Related]

  • 14. [Use of cyproheptadine (Peritol) as a drug blocking corticotropin secretion in the treatment of Cushing's syndrome].
    Komissarenko IV, Cheban AK, Rybakov SI, Pomerantsev IuV, Slavnov VI.
    Probl Endokrinol (Mosk); 1981 Feb 28; 27(6):39-42. PubMed ID: 6275378
    [Abstract] [Full Text] [Related]

  • 15. Studies on circulating met-enkephalin and beta-endorphin: normal subjects and patients with renal and adrenal disease.
    Smith R, Grossman A, Gaillard R, Clement-Jones V, Ratter S, Mallinson J, Lowry PJ, Besser GM, Rees LH.
    Clin Endocrinol (Oxf); 1981 Sep 28; 15(3):291-300. PubMed ID: 6273029
    [No Abstract] [Full Text] [Related]

  • 16. [Influence of experimental hemorrhagic shock on plasma beta-endorphin and beta-lipotropin levels].
    Kudo T, Kudo M, Yao M, Ishihara H, Oyama T.
    Masui; 1983 Aug 28; 32(8):937-42. PubMed ID: 6319771
    [No Abstract] [Full Text] [Related]

  • 17. Endogenous opioids and hypothalamic-pituitary-adrenal function in obesity and anorexia nervosa.
    Cavagnini F, Invitti C, Dubini A, Danesi L, Silvestri G, Passamonti M, Magella A, Morabito F.
    Adv Biochem Psychopharmacol; 1987 Aug 28; 43():273-81. PubMed ID: 3035891
    [No Abstract] [Full Text] [Related]

  • 18. Cyproheptadine in the control of Cushing's disease.
    Hsu TH, Gann DS, Tsan KW, Russell RP.
    Johns Hopkins Med J; 1981 Aug 28; 149(2):77-83. PubMed ID: 6265685
    [Abstract] [Full Text] [Related]

  • 19. [Studies on drug therapy of Cushing's syndrome].
    Winkelmann W, Fricke U, Hackenberg K, Heesen D, Hoff HG, Hummerich W, Liesen H.
    Verh Dtsch Ges Inn Med; 1981 Aug 28; 83():1337-40. PubMed ID: 347777
    [No Abstract] [Full Text] [Related]

  • 20. Human plasma immunoreactive lipotropin and adrenocorticotropin in normal subjects and in patients with pituitary-adrenal disease.
    Krieger DT, Liotta AS, Suda T, Goodgold A, Condon E.
    J Clin Endocrinol Metab; 1979 Apr 28; 48(4):566-71. PubMed ID: 219000
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.